市場調査レポート

商品コード

1365617

静脈内機器市場：製品タイプ別、エンドユーザー別：世界の機会分析と産業予測、2023～2032年

Intravenous Equipment Market By Product Type (IV catheters, Infusion pumps, Administration sets, Needleless connectors, Others), By End User (Hospitals & clinics, Homecare settings, Others): Global Opportunity Analysis & Industry Forecast, 2023-2032

出版日: 2023年07月01日 | 発行: Allied Market Research

| ページ情報: 英文 250 Pages | 納期: 2～3営業日

価格

Cloud Access (Single User License)

USD 3,570 560,989円

レポートのクラウドアクセスでご利用頂けるライセンスです。ウェブポータルで配信され、60日間レポートにアクセスできます。この期間を過ぎるとレポートへのアクセスは失効します。コンテンツのダウンロード、印刷、共有、コピー＆ペーストはできません。

PDF (Business License)

USD 5,730 900,412円

レポートPDFをご利用いただけるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDFl内のテキスト等のコピー＆ペーストは可能です。印刷は5回可能です。追加料金を支払うことで、2～5ユーザーを収容できるようにアップグレードできます。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 9,600 1,508,544円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Allied Market Researchの最新レポート「静脈内機器市場」によると、静脈内機器市場は2022年に150億米ドルと評価され、2023年から2032年にかけてCAGR 5.9%で成長し、2032年には267億米ドルに達すると推定されています。

静脈内（IV）機器とは、静脈内療法で使用される器具や装置のことで、静脈を通じて患者の血流に直接、水分や薬物、栄養分を送り込む医療処置のことです。点滴療法は、水分補給、薬剤投与、輸血、栄養補給など、さまざまな目的で一般的に行われています。静脈内機器の例としては、静脈に挿入してアクセスを確保する針やカテーテル、点滴バッグや容器と患者をつなぐ柔軟なチューブ、流量を制御・調節して正確な輸液を確保する電子機器である輸液ポンプなどがあります。

静脈内機器市場の成長を促す主な要因は、慢性疾患を患う人々の増加、老人人口の増加、静脈内機器技術の継続的な進歩です。点滴療法の需要は、がん、糖尿病、心血管疾患、感染症などの慢性疾患の罹患率が上昇していることが背景にあります。静脈内投与は、薬剤、輸液、栄養を直接的かつ効率的に投与できるため、慢性疾患の患者にとって極めて重要な治療法となっています。加えて、世界の人口動態は大きく変化しており、高齢者人口が急速に増加しています。高齢者は慢性疾患を発症しやすく、頻繁な入院や治療が必要となります。点滴療法は、高齢者患者に支持療法を提供する上で重要な役割を果たしています。このように、高齢者人口の増加が静脈内機器市場の成長に寄与しています。

さらに、静脈内機器技術の継続的な進歩により、点滴療法の安全性、精度、使いやすさが向上しています。スマート輸液ポンプ、統合接続ソリューション、針なし点滴システムなどの技術革新により、薬物送達の効率と精度が向上し、投薬ミスのリスクが減少し、患者の転帰が改善しました。さらに、薬物吸収の迅速化、正確なドラッグデリバリー、患者のコンプライアンス向上など、静脈内治療の利点に対する認識が医療専門家や患者の間で高まっています。そのため、治療計画に静脈内療法を取り入れる医療従事者が増え、静脈内装置の需要が高まっています。

さらに、多くの国が医療・インフラの強化や質の高い医療サービスへのアクセス強化に多くの資金を投じているため、医療支出は増加の一途をたどっています。このような医療支出の増加には、高度な患者ケアに対する需要の高まりに対応するため、静脈内機器を含む必要不可欠な医療機器の調達が含まれ、市場の成長を後押ししています。さらに、救急部門や重症治療室では、患者を迅速に安定させ、救命のための薬剤や輸液を投与するために、静脈内治療に頼ることが多くなっています。世界の救急医療件数や外傷発生件数の増加が、こうした環境における静脈内機器の需要に大きく貢献しています。静脈内機器は、重要な治療を迅速かつ効率的に実施し、クリティカルケアの場面で患者の最適な転帰を確保する上で重要な役割を果たします。

静脈内機器市場は、製品タイプ、エンドユーザー、地域に区分されます。製品タイプ別では、市場は静脈カテーテル、輸液ポンプ、投与セット、ニードルレスコネクター、その他に分類されます。さらに、投与セットは溶液投与セットと血液投与セットに分類されます。エンドユーザー別では、病院・クリニック、在宅医療、その他に分類されます。地域別では、市場は北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他の欧州地域）、アジア太平洋（日本、中国、オーストラリア、インド、韓国、その他のアジア太平洋）、アジア太平洋（ブラジル、中国、アラビア、オーストラリア、インド、韓国、その他のアジア太平洋）で分析されます。世界の静脈内機器市場で事業を展開する主な主要企業は、Becton, Dickinson and Company、B. Braun SE、ICU Medical, Inc.、vygon、Baxter International Inc.、Teleflex Incorporated、3M Company、AngioDynamics, Inc.、Terumo Corporation、Poly Medicure Ltd.などです。主要企業は、製品ポートフォリオを拡大するために、製品承認や買収などの戦略を採用しています。

市場の定義と範囲
主な調査結果
- 影響要因
- 主な投資機会
ポーターのファイブフォース分析
市場力学
- 促進要因
  - 静脈内装置の技術的進歩
  - 外科手術件数の増加
  - 慢性疾患の増加
- 抑制要因
  - 厳しい規制要件
- 機会
  - 新興市場における成長機会
COVID-19市場への影響分析

第4章静脈内機器市場：製品タイプ別

概要
輸液カテーテル
輸液ポンプ
投与セット
- 投与セット静脈内機器市場：セットタイプ別
ニードルレスコネクター
その他

第5章静脈内機器市場：エンドユーザー別

概要
病院およびクリニック
在宅医療
その他

第6章静脈内機器市場：地域別

概要
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- その他
ラテンアメリカ・中東・アフリカ
- ブラジル
- サウジアラビア
- 南アフリカ
- その他

第7章競合情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合ヒートマップ
主要企業のポジショニング、2022年

第8章企業プロファイル

Becton, Dickinson and Company
B. Braun SE
ICU Medical, Inc.
Baxter International Inc.
Teleflex Incorporated.
3M Company
AngioDynamics, Inc.
Terumo Corporation
Poly Medicure Ltd.
Vygon

図表

LIST OF TABLES

TABLE 01. GLOBAL INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 02. INTRAVENOUS EQUIPMENT MARKET FOR IV CATHETERS, BY REGION, 2022-2032 ($MILLION)
TABLE 03. INTRAVENOUS EQUIPMENT MARKET FOR INFUSION PUMPS, BY REGION, 2022-2032 ($MILLION)
TABLE 04. INTRAVENOUS EQUIPMENT MARKET FOR ADMINISTRATION SETS, BY REGION, 2022-2032 ($MILLION)
TABLE 05. GLOBAL ADMINISTRATION SETS INTRAVENOUS EQUIPMENT MARKET, BY TYPE OF SET, 2022-2032 ($MILLION)
TABLE 06. INTRAVENOUS EQUIPMENT MARKET FOR NEEDLELESS CONNECTORS, BY REGION, 2022-2032 ($MILLION)
TABLE 07. INTRAVENOUS EQUIPMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 09. INTRAVENOUS EQUIPMENT MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. INTRAVENOUS EQUIPMENT MARKET FOR HOMECARE SETTINGS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. INTRAVENOUS EQUIPMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. INTRAVENOUS EQUIPMENT MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 13. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 16. U.S. INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 17. U.S. INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 18. CANADA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 19. CANADA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. MEXICO INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 21. MEXICO INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 22. EUROPE INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 23. EUROPE INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 24. EUROPE INTRAVENOUS EQUIPMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 25. GERMANY INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 26. GERMANY INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 27. FRANCE INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 28. FRANCE INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. UK INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 30. UK INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 31. ITALY INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 32. ITALY INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 33. SPAIN INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 34. SPAIN INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 35. REST OF EUROPE INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 36. REST OF EUROPE INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 37. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 38. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 40. JAPAN INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 41. JAPAN INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. CHINA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 43. CHINA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 44. INDIA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 45. INDIA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 46. AUSTRALIA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 47. AUSTRALIA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. SOUTH KOREA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 49. SOUTH KOREA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 50. REST OF ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 51. REST OF ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 52. LAMEA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 53. LAMEA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 54. LAMEA INTRAVENOUS EQUIPMENT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 55. BRAZIL INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 56. BRAZIL INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 57. SAUDI ARABIA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 58. SAUDI ARABIA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 59. SOUTH AFRICA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 60. SOUTH AFRICA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. REST OF LAMEA INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 62. REST OF LAMEA INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 63. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 64. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 65. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
TABLE 66. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 67. B. BRAUN SE: KEY EXECUTIVES
TABLE 68. B. BRAUN SE: COMPANY SNAPSHOT
TABLE 69. B. BRAUN SE: PRODUCT SEGMENTS
TABLE 70. B. BRAUN SE: PRODUCT PORTFOLIO
TABLE 71. ICU MEDICAL, INC.: KEY EXECUTIVES
TABLE 72. ICU MEDICAL, INC.: COMPANY SNAPSHOT
TABLE 73. ICU MEDICAL, INC.: PRODUCT SEGMENTS
TABLE 74. ICU MEDICAL, INC.: PRODUCT PORTFOLIO
TABLE 75. ICU MEDICAL, INC.: KEY STRATERGIES
TABLE 76. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 77. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 78. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS
TABLE 79. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 80. BAXTER INTERNATIONAL INC.: KEY STRATERGIES
TABLE 81. TELEFLEX INCORPORATED.: KEY EXECUTIVES
TABLE 82. TELEFLEX INCORPORATED.: COMPANY SNAPSHOT
TABLE 83. TELEFLEX INCORPORATED.: PRODUCT SEGMENTS
TABLE 84. TELEFLEX INCORPORATED.: PRODUCT PORTFOLIO
TABLE 85. 3M COMPANY: KEY EXECUTIVES
TABLE 86. 3M COMPANY: COMPANY SNAPSHOT
TABLE 87. 3M COMPANY: PRODUCT SEGMENTS
TABLE 88. 3M COMPANY: PRODUCT PORTFOLIO
TABLE 89. ANGIODYNAMICS, INC.: KEY EXECUTIVES
TABLE 90. ANGIODYNAMICS, INC.: COMPANY SNAPSHOT
TABLE 91. ANGIODYNAMICS, INC.: PRODUCT SEGMENTS
TABLE 92. ANGIODYNAMICS, INC.: PRODUCT PORTFOLIO
TABLE 93. TERUMO CORPORATION: KEY EXECUTIVES
TABLE 94. TERUMO CORPORATION: COMPANY SNAPSHOT
TABLE 95. TERUMO CORPORATION: PRODUCT SEGMENTS
TABLE 96. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 97. POLY MEDICURE LTD.: KEY EXECUTIVES
TABLE 98. POLY MEDICURE LTD.: COMPANY SNAPSHOT
TABLE 99. POLY MEDICURE LTD.: PRODUCT SEGMENTS
TABLE 100. POLY MEDICURE LTD.: PRODUCT PORTFOLIO
TABLE 101. VYGON: KEY EXECUTIVES
TABLE 102. VYGON: COMPANY SNAPSHOT
TABLE 103. VYGON: PRODUCT SEGMENTS
TABLE 104. VYGON: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. INTRAVENOUS EQUIPMENT MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF INTRAVENOUS EQUIPMENT MARKET,2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN INTRAVENOUS EQUIPMENT MARKET (2023-2032)
FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
FIGURE 06. MODERATE THREAT OF SUBSTITUTES
FIGURE 07. LOW INTENSITY OF RIVALRY
FIGURE 08. HIGH BARGAINING POWER OF BUYERS
FIGURE 09. GLOBAL INTRAVENOUS EQUIPMENT MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 10. INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE, 2022(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR IV CATHETERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR INFUSION PUMPS, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR ADMINISTRATION SETS, BY COUNTRY 2022 AND 2032(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR NEEDLELESS CONNECTORS, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. INTRAVENOUS EQUIPMENT MARKET, BY END USER, 2022(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR HOMECARE SETTINGS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS EQUIPMENT MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. INTRAVENOUS EQUIPMENT MARKET BY REGION, 2022(%)
FIGURE 21. U.S. INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 22. CANADA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 23. MEXICO INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 24. GERMANY INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 25. FRANCE INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 26. UK INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 27. ITALY INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 28. SPAIN INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 29. REST OF EUROPE INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 30. JAPAN INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 31. CHINA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 32. INDIA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 33. AUSTRALIA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 34. SOUTH KOREA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 35. REST OF ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 36. BRAZIL INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 37. SAUDI ARABIA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 38. SOUTH AFRICA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 39. REST OF LAMEA INTRAVENOUS EQUIPMENT MARKET, 2022-2032 ($MILLION)
FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 44. COMPETITIVE DASHBOARD
FIGURE 45. COMPETITIVE HEATMAP: INTRAVENOUS EQUIPMENT MARKET
FIGURE 46. TOP PLAYER POSITIONING, 2022
FIGURE 47. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 48. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 49. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 50. B. BRAUN SE: NET SALES, 2020-2022 ($MILLION)
FIGURE 51. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 52. B. BRAUN SE: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 53. ICU MEDICAL, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 54. ICU MEDICAL, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 55. BAXTER INTERNATIONAL INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 56. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 57. BAXTER INTERNATIONAL INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 58. 3M COMPANY: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 59. 3M COMPANY: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 60. 3M COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 61. 3M COMPANY: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 62. ANGIODYNAMICS, INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 63. ANGIODYNAMICS, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 64. ANGIODYNAMICS, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 65. TERUMO CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 66. TERUMO CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 67. TERUMO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 68. POLY MEDICURE LTD.: NET REVENUE, 2020-2022 ($MILLION)

Product Code: A10856

According to a new report published by Allied Market Research, titled, "Intravenous Equipment Market," The intravenous equipment market was valued at $15.0 billion in 2022, and is estimated to reach $26.7 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032.

Intravenous (IV) equipment refers to the tools and devices used in intravenous therapy, a medical procedure that involves delivering fluids, medications, or nutrients directly into a patient's bloodstream through a vein. IV therapy is commonly used for various purposes, including hydration, administering medications, blood transfusions and nutritional support. Examples of intravenous equipment include needles or catheters that are inserted into a vein to create access, flexible tubing's that connects the IV bag or container to the patient and infusion pumps are electronic devices that control and regulate the flow rate, ensuring precise delivery.

The major factors driving the growth of the intravenous equipment market are the increase in number of people suffering from chronic conditions, rise in geriatric population, and continuous advancements in IV equipment technology. The demand for IV therapy is driven by the rising incidence of chronic diseases such cancer, diabetes, cardiovascular problems, and infectious diseases. Intravenous administration allows for the direct and efficient delivery of medications, fluids and nutrition, making it a crucial treatment method for patients with chronic conditions. In addition, world's population is experiencing a significant demographic shift, with a rapidly growing elderly population. The elderly people are more prone to developing chronic illnesses, which necessitate frequent hospital stays and medical treatment. IV therapy plays a vital role in providing supportive care to geriatric patients. Thus, the increasing geriatric population is contributing to the growth of the intravenous equipment market.

Further, continuous advancements in intravenous equipment technology have improved safety, precision and ease of use in administering intravenous therapy. Innovations such as smart infusion pumps, integrated connectivity solutions and needleless IV systems have enhanced the efficiency and accuracy of drug delivery, reduced the risk of medication errors and improved patient outcomes. Furthermore, growing awareness about the benefits of intravenous therapy, such as faster drug absorption, precise medication delivery and improved patient compliance, has increased among healthcare professionals and patients. Thus, more medical practitioners are incorporating IV therapy into their treatment plans, leading to a higher demand for intravenous equipment.

Additionally, as many nations invest more funds in enhancing healthcare infrastructure and boosting access to high-quality medical services, healthcare spending keeps rising. This increased healthcare spending encompasses the procurement of essential medical equipment, including IV equipment, to meet the growing demand for advanced patient care, thereby propelling the market growth. In addition, emergency departments and critical care units frequently rely on IV therapy to stabilize patients quickly and administer life-saving medications or fluids. The rising number of emergency care cases and trauma incidents worldwide has significantly contributed to the demand for IV equipment in these settings. IV equipment plays a vital role in delivering essential treatments promptly and efficiently, ensuring optimal patient outcomes in critical care scenarios.

The intravenous equipment market is segmented into product type, end user, and region. On the basis of product type, the market is categorized into IV catheters, infusion pumps, administration sets, needleless connectors, and others. Further, administration sets are classified into solution administration sets and blood administration sets. On the basis of end user, the market is segregated into hospital and clinics, homecare settings and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major key players that operate in the global intravenous equipment market are Becton, Dickinson and Company, B. Braun SE, ICU Medical, Inc., vygon, Baxter International Inc., Teleflex Incorporated., 3M Company, AngioDynamics, Inc., Terumo Corporation and Poly Medicure Ltd. The key players have adopted strategy such as product approval and acquisition to expand their product portfolio.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intravenous equipment market analysis from 2022 to 2032 to identify the prevailing intravenous equipment market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the intravenous equipment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global intravenous equipment market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

Quarterly Update and* (only available with a corporate license, on listed price)
5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
Free Upcoming Version on the Purchase of Five and Enterprise User License.
16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
Free data Pack on the Five and Enterprise User License. (Excel version of the report)
Free Updated report if the report is 6-12 months old or older.
24-hour priority response*
Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

Regulatory Guidelines
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis

Key Market Segments

By Product Type

IV catheters
Infusion pumps
Administration sets
- Type of set
- Solution administration sets
- Blood administration sets.
Needleless connectors
Others

By End User

Hospitals and clinics
Homecare settings
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

AngioDynamics, Inc.
Becton, Dickinson and Company
Vygon
3M Company
Terumo Corporation
Poly Medicure Ltd.
B. Braun SE
ICU Medical, Inc.
Baxter International Inc.
Teleflex Incorporated.

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. High bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Low intensity of rivalry
- 3.3.5. High bargaining power of buyers
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Technological advancements in intravenous equipment
  - 3.4.1.2. Growing number of surgical procedures
  - 3.4.1.3. Growing prevalence of chronic diseases

3.4.2. Restraints
- 3.4.2.1. Stringent regulatory requirements

3.4.3. Opportunities
- 3.4.3.1. Growth opportunities in emerging markets

3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE

4.1. Overview
- 4.1.1. Market size and forecast
4.2. IV catheters
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. Infusion pumps
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Administration sets
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- 4.4.4. Administration sets Intravenous Equipment Market by Type of set
4.5. Needleless connectors
- 4.5.1. Key market trends, growth factors and opportunities
- 4.5.2. Market size and forecast, by region
- 4.5.3. Market share analysis by country
4.6. Others
- 4.6.1. Key market trends, growth factors and opportunities
- 4.6.2. Market size and forecast, by region
- 4.6.3. Market share analysis by country

CHAPTER 5: INTRAVENOUS EQUIPMENT MARKET, BY END USER

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Hospitals and clinics
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Homecare settings
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Others
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country

CHAPTER 6: INTRAVENOUS EQUIPMENT MARKET, BY REGION

6.1. Overview
- 6.1.1. Market size and forecast By Region
6.2. North America
- 6.2.1. Key trends and opportunities
- 6.2.2. Market size and forecast, by Product Type
- 6.2.3. Market size and forecast, by End User
- 6.2.4. Market size and forecast, by country
  - 6.2.4.1. U.S.
  - 6.2.4.1.1. Key market trends, growth factors and opportunities
  - 6.2.4.1.2. Market size and forecast, by Product Type
  - 6.2.4.1.3. Market size and forecast, by End User
  - 6.2.4.2. Canada
  - 6.2.4.2.1. Key market trends, growth factors and opportunities
  - 6.2.4.2.2. Market size and forecast, by Product Type
  - 6.2.4.2.3. Market size and forecast, by End User
  - 6.2.4.3. Mexico
  - 6.2.4.3.1. Key market trends, growth factors and opportunities
  - 6.2.4.3.2. Market size and forecast, by Product Type
  - 6.2.4.3.3. Market size and forecast, by End User
6.3. Europe
- 6.3.1. Key trends and opportunities
- 6.3.2. Market size and forecast, by Product Type
- 6.3.3. Market size and forecast, by End User
- 6.3.4. Market size and forecast, by country
  - 6.3.4.1. Germany
  - 6.3.4.1.1. Key market trends, growth factors and opportunities
  - 6.3.4.1.2. Market size and forecast, by Product Type
  - 6.3.4.1.3. Market size and forecast, by End User
  - 6.3.4.2. France
  - 6.3.4.2.1. Key market trends, growth factors and opportunities
  - 6.3.4.2.2. Market size and forecast, by Product Type
  - 6.3.4.2.3. Market size and forecast, by End User
  - 6.3.4.3. UK
  - 6.3.4.3.1. Key market trends, growth factors and opportunities
  - 6.3.4.3.2. Market size and forecast, by Product Type
  - 6.3.4.3.3. Market size and forecast, by End User
  - 6.3.4.4. Italy
  - 6.3.4.4.1. Key market trends, growth factors and opportunities
  - 6.3.4.4.2. Market size and forecast, by Product Type
  - 6.3.4.4.3. Market size and forecast, by End User
  - 6.3.4.5. Spain
  - 6.3.4.5.1. Key market trends, growth factors and opportunities
  - 6.3.4.5.2. Market size and forecast, by Product Type
  - 6.3.4.5.3. Market size and forecast, by End User
  - 6.3.4.6. Rest of Europe
  - 6.3.4.6.1. Key market trends, growth factors and opportunities
  - 6.3.4.6.2. Market size and forecast, by Product Type
  - 6.3.4.6.3. Market size and forecast, by End User
6.4. Asia-Pacific
- 6.4.1. Key trends and opportunities
- 6.4.2. Market size and forecast, by Product Type
- 6.4.3. Market size and forecast, by End User
- 6.4.4. Market size and forecast, by country
  - 6.4.4.1. Japan
  - 6.4.4.1.1. Key market trends, growth factors and opportunities
  - 6.4.4.1.2. Market size and forecast, by Product Type
  - 6.4.4.1.3. Market size and forecast, by End User
  - 6.4.4.2. China
  - 6.4.4.2.1. Key market trends, growth factors and opportunities
  - 6.4.4.2.2. Market size and forecast, by Product Type
  - 6.4.4.2.3. Market size and forecast, by End User
  - 6.4.4.3. India
  - 6.4.4.3.1. Key market trends, growth factors and opportunities
  - 6.4.4.3.2. Market size and forecast, by Product Type
  - 6.4.4.3.3. Market size and forecast, by End User
  - 6.4.4.4. Australia
  - 6.4.4.4.1. Key market trends, growth factors and opportunities
  - 6.4.4.4.2. Market size and forecast, by Product Type
  - 6.4.4.4.3. Market size and forecast, by End User
  - 6.4.4.5. South Korea
  - 6.4.4.5.1. Key market trends, growth factors and opportunities
  - 6.4.4.5.2. Market size and forecast, by Product Type
  - 6.4.4.5.3. Market size and forecast, by End User
  - 6.4.4.6. Rest of Asia-Pacific
  - 6.4.4.6.1. Key market trends, growth factors and opportunities
  - 6.4.4.6.2. Market size and forecast, by Product Type
  - 6.4.4.6.3. Market size and forecast, by End User
6.5. LAMEA
- 6.5.1. Key trends and opportunities
- 6.5.2. Market size and forecast, by Product Type
- 6.5.3. Market size and forecast, by End User
- 6.5.4. Market size and forecast, by country
  - 6.5.4.1. Brazil
  - 6.5.4.1.1. Key market trends, growth factors and opportunities
  - 6.5.4.1.2. Market size and forecast, by Product Type
  - 6.5.4.1.3. Market size and forecast, by End User
  - 6.5.4.2. Saudi Arabia
  - 6.5.4.2.1. Key market trends, growth factors and opportunities
  - 6.5.4.2.2. Market size and forecast, by Product Type
  - 6.5.4.2.3. Market size and forecast, by End User
  - 6.5.4.3. South Africa
  - 6.5.4.3.1. Key market trends, growth factors and opportunities
  - 6.5.4.3.2. Market size and forecast, by Product Type
  - 6.5.4.3.3. Market size and forecast, by End User
  - 6.5.4.4. Rest of LAMEA
  - 6.5.4.4.1. Key market trends, growth factors and opportunities
  - 6.5.4.4.2. Market size and forecast, by Product Type
  - 6.5.4.4.3. Market size and forecast, by End User

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

8.1. Becton, Dickinson and Company
- 8.1.1. Company overview
- 8.1.2. Key Executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
- 8.1.6. Business performance
8.2. B. Braun SE
- 8.2.1. Company overview
- 8.2.2. Key Executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business performance
8.3. ICU Medical, Inc.
- 8.3.1. Company overview
- 8.3.2. Key Executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business performance
- 8.3.7. Key strategic moves and developments
8.4. Baxter International Inc.
- 8.4.1. Company overview
- 8.4.2. Key Executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
- 8.4.6. Business performance
- 8.4.7. Key strategic moves and developments
8.5. Teleflex Incorporated.
- 8.5.1. Company overview
- 8.5.2. Key Executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.5.6. Business performance
8.6. 3M Company
- 8.6.1. Company overview
- 8.6.2. Key Executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
- 8.6.6. Business performance
8.7. AngioDynamics, Inc.
- 8.7.1. Company overview
- 8.7.2. Key Executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
- 8.7.6. Business performance
8.8. Terumo Corporation
- 8.8.1. Company overview
- 8.8.2. Key Executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
- 8.8.6. Business performance
8.9. Poly Medicure Ltd.
- 8.9.1. Company overview
- 8.9.2. Key Executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
- 8.9.6. Business performance
8.10. Vygon
- 8.10.1. Company overview
- 8.10.2. Key Executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio

静脈内機器市場：製品タイプ別、エンドユーザー別：世界の機会分析と産業予測、2023～2032年

Intravenous Equipment Market By Product Type (IV catheters, Infusion pumps, Administration sets, Needleless connectors, Others), By End User (Hospitals & clinics, Homecare settings, Others): Global Opportunity Analysis & Industry Forecast, 2023-2032

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章静脈内機器市場：製品タイプ別

第5章静脈内機器市場：エンドユーザー別

第6章静脈内機器市場：地域別

第7章競合情勢

第8章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Product Type

By End User

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE

CHAPTER 5: INTRAVENOUS EQUIPMENT MARKET, BY END USER

CHAPTER 6: INTRAVENOUS EQUIPMENT MARKET, BY REGION

CHAPTER 7: COMPETITIVE LANDSCAPE

CHAPTER 8: COMPANY PROFILES

静脈内機器市場：製品タイプ別、エンドユーザー別：世界の機会分析と産業予測、2023～2032年

Intravenous Equipment Market By Product Type (IV catheters, Infusion pumps, Administration sets, Needleless connectors, Others), By End User (Hospitals & clinics, Homecare settings, Others): Global Opportunity Analysis & Industry Forecast, 2023-2032

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

第4章 静脈内機器市場：製品タイプ別

第5章 静脈内機器市場：エンドユーザー別

第6章 静脈内機器市場：地域別

第7章 競合情勢

第8章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Benefits For Stakeholders

Key Market Segments

By Product Type

By End User

By Region

Key Market Players:

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

CHAPTER 2: EXECUTIVE SUMMARY

CHAPTER 3: MARKET OVERVIEW

CHAPTER 4: INTRAVENOUS EQUIPMENT MARKET, BY PRODUCT TYPE

CHAPTER 5: INTRAVENOUS EQUIPMENT MARKET, BY END USER

CHAPTER 6: INTRAVENOUS EQUIPMENT MARKET, BY REGION

CHAPTER 7: COMPETITIVE LANDSCAPE

CHAPTER 8: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場概要

第4章静脈内機器市場：製品タイプ別

第5章静脈内機器市場：エンドユーザー別

第6章静脈内機器市場：地域別

第7章競合情勢

第8章企業プロファイル